Vacciguard Novel Vaccines

Main Menu

• About VacciGuard
• Technology
  • VacciGuard's Technology
  • Proof of Concept
  • Advantages of Technology
  • Technology
    • VacciGuard's Technology
    • Proof of Concept
    • Advantages of VacciGuard's Technology
• Vaccine Pipeline
  • Prevention and Therapeutic Targets
  • Lung Cancer
    • Lung Cancer - The Problem
    • VacciGuard Lung Vaccines
    • Lung Cancer - Animal Studies
  • West Nile Virus
    • West Nile Virus - The Problem
    • VacciGuard WNV Vaccines
    • WNV Animal Studies
  • Prevention and Therapeutic Targets
    • Prevention and Therapeutic Targets
• The Market
  • Vacciguard's Potential Market
  • The Need
  • Existing Vaccination Technologies
  • The Market
    • The Need
    • Vacciguard's Potential Market
    • Existing Vaccination Technologies
• The Team
  • Anat Eitan - Founder and CEO
  • Prof. Irun Cohen - Main Inventor
  • Scientific Advisory Board
    • Prof. Shai Ashkenazi
    • Dr. Stephen Udem
    • Prof. Mati Fridkin
    • Prof. Myron Levin
    • Dr. Irit Pinchasi
    • Prof. Angel Progador
    • Prof. Bracha Rager
    • Prof. Meir Wilcheck
  • Anat Eitan - Founder and CEO
    • Anat Eitan
  • Prof. Irun Cohen - Main Inventor
    • Prof. Irun Cohen
• From the Press
  • Vacciguard: vanquishing deadly diseases
  • Under the Radar (Hebrew)

Left Menu

• Present Status
• Contact Us
• Related Articles